Cargando…
The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis
INTRODUCTION: Metabolic-associated fatty liver disease (MAFLD) is a hepatic manifestation of metabolic syndrome (MS). MAFLD patients have a higher prevalence of COVID-19. MAFLD also is associated with worse clinical outcomes of COVID-19, such as disease severity, intensive care unit (ICU) admission...
Autores principales: | Hayat, Umar, Ashfaq, Muhammad Zubair, Johnson, Luke, Ford, Ryan, Wuthnow, Chelsea, Kadado, Kevin, El Jurdi, Katia, Okut, Hayrettin, Kilgore, William Ransom, Assi, Maha, Siddiqui, Ali A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Kansas Medical Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311786/ https://www.ncbi.nlm.nih.gov/pubmed/35899064 http://dx.doi.org/10.17161/kjm.vol15.16522 |
Ejemplares similares
-
Improving Stewardship of Clostridioides difficile Testing with EMR and Provider Phone Calls
por: Joslin, Joseph, et al.
Publicado: (2022) -
EUS-guided versus percutaneous transhepatic cholangiography biliary drainage for obstructed distal malignant biliary strictures in patients who have failed endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis
por: Hayat, Umar, et al.
Publicado: (2022) -
Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease
por: Kirkpatrick, Kennedy, et al.
Publicado: (2021) -
WATS(3D) versus forceps biopsy in screening for Barrett’s esophagus: experience in community endoscopy centers
por: Agha, Yasmine Hussein, et al.
Publicado: (2021) -
Symptomatic Colonic Metastasis in a Patient with Non-Small Cell Lung Carcinoma
por: Bharwad, Aastha, et al.
Publicado: (2022)